Zacks Investment Research on MSN
Vertex Plunges Around 24% in Six Months: How to Play the Stock
Vertex Pharmaceuticals Incorporated VRTX stock has declined 23.6% in the past six months, mainly due to recent pipeline ...
Vertex Pharmaceuticals has a lot of buy and hold ratings, but there aren't any sell ratings from Wall Street analysts. Around ...
Jupiter Endovascular announced today that its Vertex catheter received FDA 510(k) clearance for the insertion of endovascular ...
Vertex Pharmaceuticals Incorporated just reported a robust Q2 with earnings per share of $4.52, surpassing estimates and ...
Vertex Pharmaceuticals Incorporated made headlines with a notable investment by Alaethes Wealth LLC, which scooped up 3,051 ...
(BAC) highlights the Vertex® evaporative condenser, where peak reliability meets easy maintenance with enhanced materials, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback